AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday. ​​The jab would be the third available for the 27-nation EU after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.

All your Asset management needs with Global Asset Management Seoul Korea Magazine

This post was originally published on this site

Share.

Comments are closed.